Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

A recent study discusses the clinical characteristics and outcomes of patients with SARDs who were previously vaccinated against SARS-CoV-2.

11 Aug 2021

University of Ottawa announces compulsory vaccination for all students and staff visiting the campus

Today, the University of Ottawa announced that vaccination would be mandatory for all students, faculty, staff, and anyone returning to or visiting campus as of September 7th, 2021.

11 Aug 2021

UC Davis epidemiologist turns to colleagues for cancer care

Brad Pollock knows a lot about cancer. In addition to his appointments as chair of the UC Davis Public Health Sciences Department and associate dean for public health sciences, Pollock is an expert in cancer epidemiology, including the study of what causes cancer, how it spreads and cancer prevention.

11 Aug 2021

Socioeconomic privilege and political ideology correlate to racial disparities in COVID-19 vaccination

Income, educational attainment, and political ideology all play into racial disparities in vaccination rates that have left African Americans more vulnerable to COVID-19, finds new research from the Center for Health Information and Decision Systems at the University of Maryland's Robert H. Smith School of Business.

11 Aug 2021

UC San Diego’s wastewater surveillance system enables early detection of most COVID-19 cases

People infected with SARS-CoV-2, the virus that causes COVID-19, are known to shed it in their stool, even if they aren't experiencing any symptoms.

11 Aug 2021

Mount Sinai study discovers an important clue to multisystem inflammatory syndrome in children

Mount Sinai researchers have found an important clue to a rare but serious aftereffect of COVID-19 in children, known as a multisystem inflammatory syndrome in children or MIS-C.

11 Aug 2021

Cigna introduces first voice-activated test to evaluate stress levels

Cigna International announces the launch of the Cigna StressWaves Test, a free online tool that analyses acoustic and semantic voice patterns to evaluate stress levels.

11 Aug 2021

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

World Health Organization (WHO) guidelines indicate the optimal timing of vaccination among specific groups based on the probability of infection and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), e.g., health care workers providing direct care or acute disease and death (e.g., older people, organ transplant recipients).

11 Aug 2021

A new promising target for broad-spectrum therapeutics against coronaviruses

A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.

11 Aug 2021

COVID-19 booster shot in autumn will effectively protect against existing and future variants

Scientists at the University of Nottingham have confirmed that an autumn 'booster' dose of a Covid-19 vaccine will be an effective way to protect people from existing, and potentially future, variants of concern.

11 Aug 2021

COVID-19 vaccines offer better protection than natural immunity alone

Now, the U.S. Centers for Disease Control and Prevention (CDC) reports that among people who were previously infected with SARS-CoV-2, those who were still unvaccinated are more likely to be reinfected than those fully vaccinated after prior infection.

11 Aug 2021

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Scientists from Germany and Belgium have recently described the immunogenicity of a plant-based virus-like particle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine induces robust antibody and T cell responses for at least 6 months. Moreover, the vaccine demonstrates potent neutralizing efficacy against the B.1.1.7, B.1.351, and P1 variants of SARS-CoV-2.

11 Aug 2021

Pandemic News and Research

Further Reading

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

University of Ottawa announces compulsory vaccination for all students and staff visiting the campus

UC Davis epidemiologist turns to colleagues for cancer care

Socioeconomic privilege and political ideology correlate to racial disparities in COVID-19 vaccination

UC San Diego’s wastewater surveillance system enables early detection of most COVID-19 cases

Mount Sinai study discovers an important clue to multisystem inflammatory syndrome in children

Cigna introduces first voice-activated test to evaluate stress levels

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

A new promising target for broad-spectrum therapeutics against coronaviruses

COVID-19 booster shot in autumn will effectively protect against existing and future variants

COVID-19 vaccines offer better protection than natural immunity alone

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Green spaces, especially forest, reduce COVID-19 incidence, study says

Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model

High alcohol consumption increases risk of SARS-CoV-2 infection, finds US student study

Natural vs. vaccine-induced COVID-19 immunity

Genosensors enable low-cost and rapid SARS-CoV-2 detection

IMBA researchers may have found the "Achilles' heel" of SARS-CoV-2 virus

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News